Literature DB >> 1851868

Expression, purification, and properties of recombinant encephalomyocarditis virus RNA-dependent RNA polymerase.

S Sankar1, A G Porter.   

Abstract

Encephalomyocarditis (EMC) virus RNA-dependent RNA polymerase was expressed in Escherichia coli as a fusion protein with glutathione S-transferase (GST), which allowed easy purification of the fusion protein by affinity chromatography on immobilized glutathione. Inclusion of a thrombin cleavage site between the GST carrier and the viral enzyme facilitated the release of purified mature EMC virus RNA polymerase from the GST carrier by proteolysis with thrombin. The purified recombinant enzyme has a molecular mass of about 52 kDa and is recognized by polyclonal immune serum raised against a peptide sequence corresponding to the C-terminal region of the protein. The recombinant enzyme comigrates with immunoprecipitated EMC virus RNA polymerase from infected mouse L929 cell extracts when run in parallel lanes on a sodium dodecyl sulfate-polyacrylamide gel. The enzyme exhibits rifampin-resistant, poly(A)-dependent poly(U) polymerase activity and RNA polymerase activity, which are both oligo(U) dependent. Template-size products are synthesized in in vitro reactions with EMC virus genomic RNA or globin mRNA. The availability of recombinant EMC virus RNA polymerase in a purified form will allow biochemical analysis of its role in the replication of the virus as well as structure-function studies of this unique class of enzyme.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1851868      PMCID: PMC240947     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  The host protein required for in vitro replication of poliovirus is a protein kinase that phosphorylates eukaryotic initiation factor-2.

Authors:  C D Morrow; G F Gibbons; A Dasgupta
Journal:  Cell       Date:  1985-04       Impact factor: 41.582

2.  Synthesis of plus- and minus-strand RNA from poliovirion RNA template in vitro.

Authors:  T D Hey; O C Richards; E Ehrenfeld
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

3.  Lack of evidence for VPg priming of poliovirus RNA synthesis in the host factor-dependent in vitro replicase reaction.

Authors:  N C Andrews; D Baltimore
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

4.  Initiation of poliovirus plus-strand RNA synthesis in a membrane complex of infected HeLa cells.

Authors:  N Takeda; R J Kuhn; C F Yang; T Takegami; E Wimmer
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

5.  Enzymatic activity of poliovirus RNA polymerase synthesized in Escherichia coli from viral cDNA.

Authors:  M A Rothstein; O C Richards; C Amin; E Ehrenfeld
Journal:  Virology       Date:  1988-06       Impact factor: 3.616

6.  Analysis of RNA synthesis of type 1 poliovirus by using an in vitro molecular genetic approach.

Authors:  H Toyoda; C F Yang; N Takeda; A Nomoto; E Wimmer
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

7.  Host factor-induced template modification during synthesis of poliovirus RNA in vitro.

Authors:  T D Hey; O C Richards; E Ehrenfeld
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

8.  Antisense oligonucleotide inhibition of encephalomyocarditis virus RNA translation.

Authors:  S Sankar; K C Cheah; A G Porter
Journal:  Eur J Biochem       Date:  1989-09-01

9.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

10.  Poliovirus replicase stimulation by terminal uridylyl transferase.

Authors:  N C Andrews; D Levin; D Baltimore
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

View more
  13 in total

1.  Molecular and ultrastructural analysis of heavy membrane fractions associated with the replication of Kunjin virus RNA.

Authors:  P W Chu; E G Westaway
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Norovirus proteinase-polymerase and polymerase are both active forms of RNA-dependent RNA polymerase.

Authors:  Gaël Belliot; Stanislav V Sosnovtsev; Kyeong-Ok Chang; Vijay Babu; Uzo Uche; Jamie J Arnold; Craig E Cameron; Kim Y Green
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

3.  Synthesis of novel products in vitro by an RNA-dependent RNA polymerase.

Authors:  C Song; A E Simon
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

4.  Epitope mapping of monoclonal antibodies raised to recombinant Mengo 3D polymerase.

Authors:  H Duque; A C Palmenberg
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

5.  Role of the 3'-untranslated regions of alfalfa mosaic virus RNAs in the formation of a transiently expressed replicase in plants and in the assembly of virions.

Authors:  A C Vlot; L Neeleman; H J Linthorst; J F Bol
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

6.  Localization of binding site for encephalomyocarditis virus RNA polymerase in the 3'-noncoding region of the viral RNA.

Authors:  T Cui; A G Porter
Journal:  Nucleic Acids Res       Date:  1995-02-11       Impact factor: 16.971

7.  Synthesis of potato virus X RNAs by membrane-containing extracts.

Authors:  S V Doronin; C Hemenway
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

8.  Mutation analysis of the GDD sequence motif of a calicivirus RNA-dependent RNA polymerase.

Authors:  A L Vázquez; J M Alonso; F Parra
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

9.  Foot-and-mouth disease virus particles contain replicase protein 3D.

Authors:  J F Newman; P G Piatti; B M Gorman; T G Burrage; M D Ryan; M Flint; F Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

10.  Coupled translation and replication of poliovirus RNA in vitro: synthesis of functional 3D polymerase and infectious virus.

Authors:  D J Barton; J B Flanegan
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.